Comparison of remimazolam and sevoflurane on arterial oxygenation during one-lung ventilation in thoracoscopic surgery: a randomized controlled trial
Korean Journal of Anesthesiology · 2025
DOI: 10.4097/kja.25376 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Korean Journal of Anesthesiology, 2025. Verfasst von Hong-Sik Shon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine, Yangsan, Korea. Hauptthemen laut MEDLINE: Sevoflurane, One-Lung Ventilation, Anesthetics, Inhalation, Oxygen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
One-lung ventilation (OLV) during thoracoscopic surgery can impair oxygenation due to increased intrapulmonary shunts. Remimazolam has gained attention for its hemodynamic stability and rapid recovery profile; however, its effects on arterial oxygenation during OLV remain unclear. This study aimed to compare the effects of remimazolam and sevoflurane on arterial oxygenation during OLV.
Methods
In this prospective, randomized controlled trial, 58 adult patients undergoing thoracoscopic surgery were assigned to receive either sevoflurane or remimazolam for anesthesia maintenance. Arterial blood gas analysis and hemodynamic parameters were measured at four time points: 10 min after lateral positioning during two-lung ventilation (TLV10) and 15, 30, and 60 min after initiating OLV (OLV15, OLV30, and OLV60). The primary outcome was arterial partial pressure of oxygen (PaO2) at OLV30. Secondary outcomes included time-dependent changes in PaO2, hemodynamic variables, and serum lactate levels.
Results
No significant difference in PaO2 at OLV30 was observed between groups (108.9 ± 37.9 vs. 107.0 ± 37.8 mmHg, 95% CI [−21.8 to 18.0], P = 0.815). In within-group analysis, PaO2 at OLV60 increased significantly from TLV10 in the remimazolam group (95% CI [0.3–36.8], P = 0.044), while no such improvement was observed in the sevoflurane group. Serum lactate levels exhibited a significant time-by-group interaction with a greater reduction in the remimazolam group (P = 0.021).
Conclusions
Remimazolam provided arterial oxygenation and hemodynamic stability comparable to sevoflurane during OLV. The greater reduction in serum lactate levels with remimazolam suggests its potential metabolic or immunomodulatory advantages that warrant further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine, Yangsan, Korea.
- Department of Anesthesia and Pain Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.
- Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.
Zitieren
APA
Shon, H. S., Kim, H. Y., Yoon, J. U., Kim, H. J., Park, S., Yoo, Y. M., Park, H., & Yoon, J. P. (2025). Comparison of remimazolam and sevoflurane on arterial oxygenation during one-lung ventilation in thoracoscopic surgery: a randomized controlled trial. Korean Journal of Anesthesiology. https://doi.org/10.4097/kja.25376
Vancouver
Shon HS, Kim HY, Yoon JU, Kim HJ, Park S, Yoo YM, et al. Comparison of remimazolam and sevoflurane on arterial oxygenation during one-lung ventilation in thoracoscopic surgery: a randomized controlled trial. Korean Journal of Anesthesiology. 2025. doi:10.4097/kja.25376
BibTeX
@article{Shon2025,
author = {Shon, Hong-Sik and Kim, Hee Young and Yoon, Ji-Uk and Kim, Hye-Jin and Park, Seyeon and Yoo, Yeong Min and Park, Hyeonsoo and Yoon, Jung-Pil},
title = {Comparison of remimazolam and sevoflurane on arterial oxygenation during one-lung ventilation in thoracoscopic surgery: a randomized controlled trial},
journal = {Korean Journal of Anesthesiology},
year = {2025},
doi = {10.4097/kja.25376}
}
EUVIMED